Experts at Massachusetts General Hospital have successfully performed five CV transplants using Donation after Circulatory Death donor hearts—the largest number of adult DCD heart transplants ever completed in the U.S.

After a slow start, cardiac ERAS is gaining traction in some U.S. hospitals. Proponents explain how to overcome resistance. 

Hepatitis C-positive donor hearts are a viable long-term option for patients in need of a heart transplant, researchers confirmed in JAMA Cardiology Dec. 18.

Heart transplant patients who live in areas with high levels of air pollution had a 26% higher risk of mortality due to infection in a recent study of nearly 22,000 patients in the U.S.

A study published in the European Journal of Cardiovascular Nursing Nov. 28 found that nearly half of heart patients undergoing PCI admit to not understanding or remembering the bulk of the informed consent process, leaving them without a clear picture of the procedure and its potential benefits.

People with severe but stable ischemic heart disease don’t benefit any more from invasive CV procedures than they do from optimal medical therapy and lifestyle changes alone, according to results from the highly anticipated ISCHEMIA trial.

Research published in JAMA Nov. 12 suggests that, despite the Organ Procurement and Transplant Network’s overhaul of the U.S. heart allocation system in 2018, CV transplant programs still suffer from variability in survival benefit and a lack of standardized guidelines for ranking candidates.

Women face a greater risk of bleeding and hemorrhagic stroke after PCI than men, according to a new subgroup analysis of the GLOBAL LEADERS trial.